Premier Fund Managers LTD Pacira Bio Sciences, Inc. Transaction History

Premier Fund Managers LTD

$2.82 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $3.26 Million - $4.18 Million	-117,764 Reduced 94.56%	6,769 $197,000
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $87,119 - $113,566	-3,310 Reduced 2.59%	124,533 $4.18 Million
Q3 2023 Nov 08, 2023	SELL	$30.68 - $40.09 $718,955 - $939,469	-23,434 Reduced 15.49%	127,843 $3.94 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $47.5 $5.46 Million - $7.19 Million	151,277 New	151,277 $5.98 Million
Q4 2022 Feb 09, 2023	SELL	$38.19 - $57.45 $803,097 - $1.21 Million	-21,029 Reduced 30.93%	46,971 $1.83 Million
Q4 2022 Feb 08, 2023	BUY	$38.19 - $57.45 $1.71 Million - $2.57 Million	44,750 Added 192.47%	68,000 $7.33 Million
Q3 2022 Nov 04, 2022	SELL	$51.24 - $58.89 $7.22 Million - $8.3 Million	-141,000 Reduced 85.84%	23,250 $1.26 Million
Q2 2022 Aug 09, 2022	BUY	$51.49 - $81.64 $6.75 Million - $10.7 Million	131,000 Added 393.98%	164,250 $9.63 Million
Q2 2022 Aug 08, 2022	SELL	$51.49 - $81.64 $8.64 Million - $13.7 Million	-167,893 Reduced 83.47%	33,250 $868,000
Q1 2022 May 10, 2022	BUY	$60.03 - $76.49 $1.53 Million - $1.95 Million	25,450 Added 14.49%	201,143 $15.2 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $86,346 - $111,978	-1,800 Reduced 1.01%	175,693 $10.7 Million
Q2 2021 Aug 05, 2021	BUY	$59.18 - $69.99 $224,884 - $265,962	3,800 Added 2.19%	177,493 $10.8 Million
Q1 2021 May 10, 2021	SELL	$59.31 - $78.82 $1.82 Million - $2.41 Million	-30,637 Reduced 14.99%	173,693 $12.3 Million
Q4 2020 Feb 09, 2021	BUY	$50.47 - $66.26 $3.11 Million - $4.09 Million	61,656 Added 43.21%	204,330 $12.2 Million
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $4.73 Million - $5.74 Million	91,074 Added 176.5%	142,674 $8.47 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $1.59 Million - $2.71 Million	51,600 New	51,600 $2.71 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.

Account